a public good project by the
Synthesis
Company
of California

© 2026

Esther Fernández | doi.page

0 works0 citations0 h-index

Esther Fernández

Universidad de Oviedo(ES)AdventHealth Orlando(US)GlaxoSmithKline (France)(FR)GMV Innovating Solutions (Spain)(ES)

Publications by Year

Research Areas

Malaria Research and Control, Computational Drug Discovery Methods, Synthesis and Biological Evaluation, Mosquito-borne diseases and control, Analytical chemistry methods development

Most-Cited Works

→ Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials(2008)138 cited
→ Metallic ions released from stainless steel, nickel-free, and titanium orthodontic alloys: Toxicity and DNA damage(2011)126 cited
→ Falcipain Inhibitors: Optimization Studies of the 2-Pyrimidinecarbonitrile Lead Series(2010)107 cited
→ Structural Insights into PROTAC-Mediated Degradation of Bcl-xL(2020)87 cited
→ An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS(2011)77 cited
→ Synthesis and Structure−Activity Relationships of a New Model of Arylpiperazines. 2. Three-Dimensional Quantitative Structure−Activity Relationships of Hydantoin−Phenylpiperazine Derivatives with Affinity for 5-HT_1A and α₁ Receptors. A Comparison of CoMFA Models(1997)64 cited

→ Malaria diagnosis by dipstick assay in a Honduran population with coendemic Plasmodium falciparum and Plasmodium vivax.(1998)64 cited

→ Classification of apple beverages using artificial neural networks with previous variable selection(2004)57 cited

→ Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen(2017)56 cited

→ Synthesis and Structure−Activity Relationships of a New Model of Arylpiperazines. 8. Computational Simulation of Ligand−Receptor Interaction of 5-HT_1AR Agonists with Selectivity over α₁-Adrenoceptors(2005)56 cited